Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by famaron Jul 16, 2020 3:09pm

280 Views

Post# 31277532

RE:RE:RE:RE:RE:Flat line accumulation ..+/- .05 on regular basis

WOW....Forty Seven run was amazing one. I would say build it and they will come eventually. Who get to share in the ATM prior to big run may be determined already. But these buying opportunities below $3.00 CAD I think is well worth the wait.

I think we got caught with the Covid19 dilemma. Very difficult to get a block without a big price increase. MRNA had some issues prior but its rectified so too if ONC has a couple issues at this stage they can re-group and make changes. I would accumulate at these levels.

fmb

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season